Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Continuous Flow Micro Reaction Technology. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112979461B enables high-purity Vitamin B1 intermediate production via continuous flow, offering significant cost reduction and supply chain reliability for global buyers.
Patent CN111253271A reveals a safer micro-reactor route for methyl 2-amino-3-nitrobenzoate, offering significant yield improvements and cost reduction in API manufacturing.
Patent CN112979461A reveals a continuous flow method for 3-chloro-4-oxoacetic acid amyl ester, offering higher yields and safer manufacturing for vitamin B1 intermediates.
Patent CN111253271B reveals a continuous flow method for methyl 2-amino-3-nitrobenzoate, enhancing safety and yield for ARB drug intermediates.